Peer Review reports
From: Does Losartan reduce the severity of COVID-19 in hypertensive patients?
| Original Submission | ||
|---|---|---|
| 22 Aug 2021 | Submitted | Original manuscript |
| 21 Oct 2021 | Reviewed | Reviewer Report - Zahraa Talib Khudhair |
| 2 Nov 2021 | Reviewed | Reviewer Report |
| 17 Dec 2021 | Author responded | Author comments - Ali Dehghani |
| Resubmission - Version 2 | ||
| 17 Dec 2021 | Submitted | Manuscript version 2 |
| 6 Jan 2022 | Author responded | Author comments - Ali Dehghani |
| Resubmission - Version 3 | ||
| 6 Jan 2022 | Submitted | Manuscript version 3 |
| 11 Feb 2022 | Reviewed | Reviewer Report |
| 16 Feb 2022 | Reviewed | Reviewer Report - Zahraa Talib Khudhair |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 8 Mar 2022 | Editorially accepted | |
| 19 Mar 2022 | Article published | 10.1186/s12872-022-02548-2 |
You can find further information about peer review here.